{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:50:24Z","timestamp":1794408624586,"version":"4.9.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:00:00Z","timestamp":1716681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1170925,1210644"],"award-info":[{"award-number":["1170925,1210644"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1523A0008"],"award-info":[{"award-number":["1523A0008"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["15130011"],"award-info":[{"award-number":["15130011"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1170925"],"award-info":[{"award-number":["1170925"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018735","name":"Fondo de Financiamiento de Centros de Investigaci\u00f3n en \u00c1reas Prioritarias","doi-asserted-by":"publisher","award":["1210644"],"award-info":[{"award-number":["1210644"]}],"id":[{"id":"10.13039\/501100018735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116841","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T18:43:30Z","timestamp":1717440210000},"page":"116841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Inhibition of glycolysis and Src\/Akt signaling reduces Caveolin-1-enhanced metastasis"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0130-3519","authenticated-orcid":false,"given":"Layla","family":"Sim\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7638-6438","authenticated-orcid":false,"given":"Keila","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"D\u00edaz-Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-9638","authenticated-orcid":false,"given":"Lisette","family":"Leyton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.G.","family":"Quest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2024.116841_bib1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116841_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried","year":"2013","journal-title":"Crit. Rev. Oncog."},{"issue":"4","key":"10.1016\/j.biopha.2024.116841_bib3","first-page":"346","article-title":"Current and future roles of targeted therapy and immunotherapy in advanced melanoma","volume":"20","author":"Olszanski","year":"2014","journal-title":"J. Manag Care Spec. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2024.116841_bib4","first-page":"519M","article-title":"Metastatic breast cancer","volume":"88","author":"Peart","year":"2017","journal-title":"Radio. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biopha.2024.116841_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"3191","key":"10.1016\/j.biopha.2024.116841_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"5930","key":"10.1016\/j.biopha.2024.116841_bib8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.biopha.2024.116841_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116841_bib10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/ijms23031155","article-title":"Cancer as a metabolic disorder","volume":"23","author":"Gyamfi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"41","key":"10.1016\/j.biopha.2024.116841_bib11","doi-asserted-by":"crossref","first-page":"24875","DOI":"10.1074\/jbc.M115.644336","article-title":"Molecular characterization of caveolin-induced membrane curvature","volume":"290","author":"Ariotti","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-cellbio-100617-062737","article-title":"Caveolae: structure, function, and relationship to disease","volume":"34","author":"Parton","year":"2018","journal-title":"Annu Rev. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116841_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10555-020-09890-x","article-title":"Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer","volume":"39","author":"Sim\u00f3n","year":"2020","journal-title":"Cancer Metastasis\u00a0Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116841_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033085","article-title":"Caveolin-1-enhanced motility and focal adhesion turnover require tyrosine-14 but not accumulation to the rear in metastatic cancer cells","volume":"7","author":"Urra","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116841_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113941","article-title":"Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells","volume":"177","author":"Ortiz","year":"2020","journal-title":"Biochem. Pharm."},{"issue":"26","key":"10.1016\/j.biopha.2024.116841_bib16","doi-asserted-by":"crossref","first-page":"40571","DOI":"10.18632\/oncotarget.9738","article-title":"Extracellular matrix-specific Caveolin-1 phosphorylation on tyrosine 14 is linked to augmented melanoma metastasis but not tumorigenesis","volume":"7","author":"Ortiz","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.116841_bib17","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.141689","article-title":"Rab5 is required for Caveolin-1-enhanced Rac1 activation, migration and invasion of metastatic cancer cells","author":"D\u00edaz","year":"2014","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.biopha.2024.116841_bib19","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3390\/cancers14122862","article-title":"Mitochondrial dysfunction and the glycolytic switch induced by caveolin-1 phosphorylation promote cancer cell migration, invasion, and metastasis","volume":"14","author":"D\u00edaz-Valdivia","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-016-0558-7","article-title":"Caveolin-1 in the regulation of cell metabolism: a cancer perspective","volume":"15","author":"Nwosu","year":"2016","journal-title":"Mol. Cancer"},{"issue":"16","key":"10.1016\/j.biopha.2024.116841_bib21","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1158\/0008-5472.CAN-12-0448","article-title":"Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription","volume":"72","author":"Ha","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.biopha.2024.116841_bib22","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1158\/0008-5472.CAN-12-3040","article-title":"Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer","volume":"73","author":"Tahir","year":"2013","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116841_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yexmp.2005.09.001","article-title":"Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues","volume":"80","author":"Kim","year":"2006","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2024.116841_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2867-14-52","article-title":"Caveolin-1 induces lamellipodia formation via an Akt-dependent pathway","volume":"14","author":"Chanvorachote","year":"2014","journal-title":"Cancer Cell Int."},{"issue":"15","key":"10.1016\/j.biopha.2024.116841_bib25","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.yexcr.2008.06.004","article-title":"Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration","volume":"314","author":"Ravid","year":"2008","journal-title":"Exp. Cell Res."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116841_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-015-2429-8","article-title":"Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1\/AKT\/mTOR pathway","volume":"406","author":"Guo","year":"2015","journal-title":"Mol. Cell Biochem"},{"issue":"6","key":"10.1016\/j.biopha.2024.116841_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1159\/000350108","article-title":"Crosstalk between PI3 kinase\/PDK1\/Akt\/Rac1 and Ras\/Raf\/MEK\/ERK pathways downstream PDGF receptor","volume":"31","author":"Niba","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2024.116841_bib28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1159\/000358679","article-title":"PTP1B inhibition causes Rac1 activation by enhancing receptor tyrosine kinase signaling","volume":"33","author":"Tsuchiya","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"24","key":"10.1016\/j.biopha.2024.116841_bib29","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1091\/mbc.e13-03-0163","article-title":"Src-mediated caveolin-1 phosphorylation affects the targeting of active Src to specific membrane sites","volume":"24","author":"Gottlieb-Abraham","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"34","key":"10.1016\/j.biopha.2024.116841_bib30","doi-asserted-by":"crossref","first-page":"31858","DOI":"10.1074\/jbc.C100271200","article-title":"Regulation of Akt\/PKB activation by tyrosine phosphorylation","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.biopha.2024.116841_bib31","doi-asserted-by":"crossref","first-page":"37459","DOI":"10.1074\/jbc.M105916200","article-title":"Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 and their role in regulating kinase activity","volume":"276","author":"Park","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2024.116841_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004686","article-title":"c-Src regulates Akt signaling in response to ghrelin via \u03b2-arrestin signaling-independent and -dependent mechanisms","volume":"4","author":"Lodeiro","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2024.116841_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/pcmr.12085","article-title":"E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells","volume":"26","author":"Lobos-Gonz\u00e1lez","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"issue":"18","key":"10.1016\/j.biopha.2024.116841_bib34","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1038\/s41388-020-1242-3","article-title":"The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis","volume":"39","author":"D\u00edaz-Valdivia","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im2001s39","article-title":"B16 as a mouse model for human melanoma","volume":"39","author":"Overwijk","year":"2000","journal-title":"Curr. Protoc. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116841_bib36","doi-asserted-by":"crossref","DOI":"10.4067\/S0370-41061999000400009","article-title":"Tama\u00f1o muestral en estudios biom\u00e9dicos","volume":"70","author":"Duffau","year":"1999","journal-title":"Rev. Chil. Pediatr."},{"issue":"2","key":"10.1016\/j.biopha.2024.116841_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/CMR.0000000000000046","article-title":"Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models","volume":"24","author":"Lobos-Gonzalez","year":"2014","journal-title":"Melanoma Res."},{"issue":"67","key":"10.1016\/j.biopha.2024.116841_bib38","doi-asserted-by":"crossref","first-page":"111943","DOI":"10.18632\/oncotarget.22955","article-title":"Anti-neoplastic drugs increase caveolin-1-dependent migration, invasion and metastasis of cancer cells","volume":"8","author":"D\u00edaz-Valdivia","year":"2017","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.biopha.2024.116841_bib39","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4161\/cc.8.16.9335","article-title":"The Akt kinases: isoform specificity in metabolism and cancer","volume":"8","author":"Gonzalez","year":"2009","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12964-019-0450-3","article-title":"Distinct functions of AKT isoforms in breast cancer: a comprehensive review","volume":"17","author":"Hinz","year":"2019","journal-title":"Cell Commun. Signal"},{"issue":"12","key":"10.1016\/j.biopha.2024.116841_bib41","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/pros.21345","article-title":"G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells","volume":"71","author":"Liu","year":"2011","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.biopha.2024.116841_bib42","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.urolonc.2014.01.005","article-title":"CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition","volume":"32","author":"Liang","year":"2014","journal-title":"Urol. Oncol.: Semin. Orig. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/19336918.2020.1827665","article-title":"MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K\/AKT signaling pathway by inhibiting CAV1","volume":"14","author":"Han","year":"2020","journal-title":"Cell Adh Migr."},{"issue":"10","key":"10.1016\/j.biopha.2024.116841_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22202","article-title":"Caveolin-1 contributes to anoikis resistance in human gastric cancer SGC-7901 cells via regulating Src-dependent EGFR-ITGB1 signaling","volume":"32","author":"Wang","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2024.116841_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.lfs.2017.11.011","article-title":"Effects of Antarctic krill docosahexaenoic acid on MCF-7 cell migration and invasion induced by the interaction of CD95 with caveolin-1","volume":"192","author":"Zheng","year":"2018","journal-title":"Life Sci."},{"issue":"24","key":"10.1016\/j.biopha.2024.116841_bib46","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1128\/MCB.23.24.9389-9404.2003","article-title":"Caveolin-1 maintains activated akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine\/threonine protein phosphatases PP1 and PP2A","volume":"23","author":"Li","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116841_bib47","doi-asserted-by":"crossref","DOI":"10.4161\/19420889.2014.972850","article-title":"A novel caveolin-1\/p85\u03b1\/Rab5\/Tiam1\/Rac1 signaling axis in tumor cell migration and invasion","volume":"7","author":"D\u00edaz","year":"2014","journal-title":"Commun. Integr. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116841_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/onc.2011.284","article-title":"Overexpression of 14-3-3\u03b6 in cancer cells activates PI3K via binding the p85 regulatory subunit","volume":"31","author":"Neal","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2024.116841_bib49","series-title":"Blood Glucose Levels","article-title":"Role of PI3K\/AKT Pathway in Insulin-Mediated Glucose Uptake","author":"\u015awiderska","year":"2020"},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biom9010029","article-title":"Impact of p85\u03b1 alterations in cancer","volume":"9","author":"Marshall","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2024.116841_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","article-title":"Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours","volume":"10","author":"Xu","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.biopha.2024.116841_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9258396","article-title":"Signal transduction pathways in breast cancer: the important role of PI3K\/Akt\/mTOR","volume":"2020","author":"Ortega","year":"2020","journal-title":"J. Oncol."},{"issue":"13","key":"10.1016\/j.biopha.2024.116841_bib53","doi-asserted-by":"crossref","first-page":"16227","DOI":"10.18632\/oncotarget.7583","article-title":"Mechanosensitive caveolin-1 activation-induced PI3K\/Akt\/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"25","key":"10.1016\/j.biopha.2024.116841_bib54","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.2174\/1381612033454126","article-title":"Src family kinases: potential targets for the treatment of human cancer and leukemia","volume":"9","author":"Warmuth","year":"2003","journal-title":"Curr. Pharm. Des."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400725X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400725X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:48:39Z","timestamp":1781650119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222400725X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":54,"alternative-id":["S075333222400725X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116841","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of glycolysis and Src\/Akt signaling reduces Caveolin-1-enhanced metastasis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116841"}}